Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Competitor Analysis: Mesothelin-Targeted Antibodies, Vaccines & T-Cells 2017 - Research and Markets

Research and Markets
Posted on: 23 Aug 17

The "Competitor Analysis: Mesothelin-Targeted Antibodies, Vaccines & T-Cells 2017" report has been added to Research and Markets' offering.

This Competitive Intelligence report about Mesothelin-Targeted Antibodies, Vaccines & T-Cells 2017 provides a competitor evaluation in the field of antibodies, vaccines and engineered chimeric antigen receptor (CAR) T-cells targeting mesothelin as of August 2017.

Mesothelin is a surface marker protein overexpressed in many cancers and is a suitable target for directing immunotherapeutics to mesothelin expressing tumors, such as malignant pleural mesothelioma, mesothelioma and pancreatic, non-small cell lung, ovarian, endometrial and gastric cancers.

The report includes a compilation of currently active projects in research and development of antibodies, vaccines and engineered T-cells directed against mesothelin. In addition, the report lists company- and institution-specific R&D pipelines of anti-Mesothelin Immunotherapeutics.

Competitor projects are listed in a tabular format providing information on:

- Drug Codes

- Target / Mechanism of Action

- Class of Compound

- Company

- Product Category

- Indication

- R&D Stage

- Additional comments with a hyperlink leading to the source of information.

Key Topics Covered:

1. Mesothelin-Targeted Antibodies, Vaccines & T-Cells 2017

- Mesothelin-Targeted Antibodies

- Mesothelin-Targeted Vaccines

- Mesothelin-Targeted Engineered CAR T-Cells

2. Corporate & Institutional Anti-Mesothelin R&D Pipelines

For more information about this report visit

View source version on

Business Wire

Last updated on: 23/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.